晶泰控股(02228.HK)今日盘中大涨5.02%,股价表现亮眼。据了解,公司与韩国知名药企JW Pharmaceutical签署战略合作协议,共同打造一系列自动化实验室和人工智能系统,推动新一代药物发现。
根据协议内容,晶泰控股将为JW部署高通量自动化合成工站、AI反应条件优化系统及智能分析平台,以满足JW在自动化药物候选分子筛选、合成与工艺优化等方向的复杂研发需求。双方希望以AI驱动药物发现,提高研发效率。
晶泰控股表示,公司自动化实验室解决方案此前已获复旦大学、中石化等标杆客户采购,但JW成为首个采购的海外药企客户。此次合作有望带动晶泰控股在生物医药领域业务进一步增长,公司前景值得市场期待。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.